Advisory Board May 3, 2022

Rae Woods:

From Advisory Board, we’re bringing you a Radio Advisory. My name is Rachel Woods. You can call me Rae. Today, I want to talk about the life sciences part of the healthcare industry. You may think of these as just the drug makers or just the device companies. But in reality, there is a critical way that life sciences interacts with the rest of the healthcare ecosystem. And that’s evidence. So to talk about the evolving role of evidence, I’ve brought three guests. We’ve got life sciences experts, Solomon Banjo and Pam Divack. We’ve also got Lou Brooks, SVP from Optum Life Sciences. Well, welcome to Radio Advisory to all three of you, Pam, Solomon, Lou. It’s been...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Big Data, Biotechnology, Conferences / Podcast, Pharma / Biotech, Technology, Trends
Former Bristol Myers CEO tapped as Novartis’ next board chair
The Power of Drug Discovery with Philip Tagari
Novartis raises forecasts as top drug sales beat Wall Street estimates
Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & more
AI Ushers in HPC Revival Says TACC’s Dan Stanzione

Share This Article